Payment overview · 2025
General Payments
$190.67
6 reported records · 1 companies
Healthcare provider profile · identity verified
Imran Shafqat, MD
Allopathic & Osteopathic Physicians|Family Medicine · KALAMAZOO, MI · NPI 1336404540
Verified facts
What the public records show
CMS Open Payments records show Imran Shafqat, MD received $190.67 in general payments during 2025 across 6 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $190.67 | 100.0% | 6 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $175.00 | 1 |
| Food and Beverage | $15.67 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| PROLIA Normalized: prolia |
Biological | Amgen Inc. | $175.00 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $15.67 | 5 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $14.15 | 4 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 772 | 194 |
| Levothyroxine Sodium | Levothyroxine Sodium | 412 | 95 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 348 | 90 |
| Gabapentin | Gabapentin | 337 | 71 |
| Amlodipine Besylate | Amlodipine Besylate | 288 | 74 |
| Omeprazole | Omeprazole | 286 | 75 |
| Metoprolol Succinate | Metoprolol Succinate | 235 | 67 |
| Losartan Potassium | Losartan Potassium | 210 | 65 |
| Trazodone Hcl | Trazodone Hcl | 208 | 44 |
| Duloxetine Hcl | Duloxetine Hcl | 199 | 36 |
| Lisinopril | Lisinopril | 199 | 61 |
| Pantoprazole Sodium | Pantoprazole Sodium | 198 | 45 |
| Jardiance | Empagliflozin | 192 | 38 |
| Metformin Hcl Er | Metformin Hcl | 192 | 45 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 186 | 60 |
| Metformin Hcl | Metformin Hcl | 173 | 39 |
| Tamsulosin Hcl | Tamsulosin Hcl | 173 | 43 |
| Furosemide | Furosemide | 158 | 36 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 141 | 32 |
| Eliquis | Apixaban | 139 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 124 | 28 |
| Alendronate Sodium | Alendronate Sodium | 123 | 30 |
| Carvedilol | Carvedilol | 113 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 105 | 39 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 99 | 21 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 98 | 28 |
| Clonazepam | Clonazepam | 97 | 17 |
| Tramadol Hcl | Tramadol Hcl | 97 | 23 |
| Bupropion Xl | Bupropion Hcl | 95 | 20 |
| Glimepiride | Glimepiride | 93 | 26 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 93 | 23 |
| Ibuprofen | Ibuprofen | 91 | 26 |
| Pravastatin Sodium | Pravastatin Sodium | 90 | 25 |
| Alprazolam | Alprazolam | 88 | 27 |
| Diclofenac Sodium | Diclofenac Sodium | 83 | 36 |
| Aripiprazole | Aripiprazole | 80 | suppressed |
| Allopurinol | Allopurinol | 79 | 14 |
| Famotidine | Famotidine | 78 | 16 |
| Topiramate | Topiramate | 78 | 21 |
| Sertraline Hcl | Sertraline Hcl | 76 | 19 |
| Hydrochlorothiazide | Hydrochlorothiazide | 74 | 26 |
| Ozempic | Semaglutide | 73 | 15 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 71 | 14 |
| Potassium Chloride | Potassium Chloride | 70 | 17 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 67 | 12 |
| Farxiga | Dapagliflozin Propanediol | 65 | 12 |
| Montelukast Sodium | Montelukast Sodium | 64 | 18 |
| Finasteride | Finasteride | 62 | 19 |
| Mirtazapine | Mirtazapine | 62 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 61 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 59 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 57 | suppressed |
| Baclofen | Baclofen | 56 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 56 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 56 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 55 | 12 |
| Ezetimibe | Ezetimibe | 54 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 53 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 53 | 17 |
| Methocarbamol | Methocarbamol | 53 | 18 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 52 | 16 |
| Simvastatin | Simvastatin | 52 | 14 |
| Lovastatin | Lovastatin | 50 | suppressed |
| Meloxicam | Meloxicam | 50 | suppressed |
| Trulicity | Dulaglutide | 48 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 47 | 16 |
| Ondansetron Odt | Ondansetron | 45 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 44 | suppressed |
| Prednisone | Prednisone | 41 | 36 |
| Clopidogrel | Clopidogrel Bisulfate | 40 | suppressed |
| Methadone Hcl | Methadone Hcl | 40 | suppressed |
| Pregabalin | Pregabalin | 40 | suppressed |
| Acyclovir | Acyclovir | 38 | suppressed |
| Buprenorphine Hcl | Buprenorphine Hcl | 38 | suppressed |
| Lamotrigine | Lamotrigine | 38 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 38 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 38 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 36 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 35 | 29 |
| Atenolol | Atenolol | 34 | suppressed |
| Celecoxib | Celecoxib | 34 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 34 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 34 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 31 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 31 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 31 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 31 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 29 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 29 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 29 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 29 | suppressed |
| Amoxicillin | Amoxicillin | 28 | 12 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 28 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 28 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 27 | suppressed |
| Estradiol | Estradiol | 27 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 27 | suppressed |
| Spironolactone | Spironolactone | 27 | suppressed |
| Ketoconazole | Ketoconazole | 26 | suppressed |
| Primidone | Primidone | 26 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 26 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 24 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 24 | suppressed |
| Rybelsus | Semaglutide | 24 | suppressed |
| Suboxone | Buprenorphine Hcl/Naloxone Hcl | 24 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 22 | suppressed |
| Torsemide | Torsemide | 22 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 22 | 13 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 20 | 13 |
| Liothyronine Sodium | Liothyronine Sodium | 20 | suppressed |
| Xarelto | Rivaroxaban | 20 | suppressed |
| Mounjaro | Tirzepatide | 19 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 19 | suppressed |
| Creon | Lipase/Protease/Amylase | 18 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 18 | suppressed |
| Fluconazole | Fluconazole | 18 | 12 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 18 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 18 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 17 | 14 |
| Bupropion Hcl | Bupropion Hcl | 17 | suppressed |
| Cephalexin | Cephalexin | 17 | 15 |
| Nitroglycerin | Nitroglycerin | 17 | 13 |
| Telmisartan | Telmisartan | 17 | suppressed |
| Colchicine | Colchicine | 16 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 16 | suppressed |
| Glipizide | Glipizide | 16 | suppressed |
| Mupirocin | Mupirocin | 16 | suppressed |
| Nystatin | Nystatin | 16 | 14 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 16 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Memantine Hcl | Memantine Hcl | 15 | suppressed |
| Olanzapine | Olanzapine | 15 | suppressed |
| Ramipril | Ramipril | 15 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 14 | suppressed |
| Diazepam | Diazepam | 14 | suppressed |
| True Comfort Safety Pen Needle | Pen Needle, Diabetic, Safety | 14 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 14 | suppressed |
| Bumetanide | Bumetanide | 13 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 13 | suppressed |
| Lorazepam | Lorazepam | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 12 | suppressed |
| Fentanyl | Fentanyl | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Invokana | Canagliflozin | 12 | suppressed |
| Klor-Con M20 | Potassium Chloride | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Omnipod Dash Pods (Gen 4) | Insulin Pump Cart,cont Inf,bt | 12 | suppressed |
| Tri-Sprintec | Norgestimate-Ethinyl Estradiol | 12 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 12 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 11 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 11 | suppressed |
| Azithromycin | Azithromycin | 11 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Dayvigo | Lemborexant | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 11 | suppressed |
| Myrbetriq | Mirabegron | 11 | suppressed |
| Novolog | Insulin Aspart | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 11 | suppressed |
| Sublocade | Buprenorphine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $190.67 · 6 records | Amgen Inc. | OTEZLA, PROLIA, REPATHA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error